ICAM1 and neoplasm: Specifically, tumor-derived PGRN promoted the polarization of TAMs to M2 macrophages, and then, PGRN-treated TAMs inhibited proliferation and activation of CD8 + T cells via ICAM-1-mediated interaction with CD8+T cells in BCa tumor microenvironment.